| S7910 |
Epacadostat (INCB024360)
|
Epacadostat (INCB024360) is a potent and selective indoleamine 2,3-dioxygenase (IDO1) inhibitor with an IC50 of 10 nM, and it displays high selectivity over other related enzymes such as IDO2 or tryptophan 2,3-dioxygenase (TDO).
|
-
Immunity, 2025, 58(1):247-262.e9
-
Mol Cell Proteomics, 2025, 24(9):101048
-
Commun Chem, 2025, 8(1):277
|
|
| S7111 |
IDO-IN-2
|
IDO-IN-2 (RG 6078, NLG-919 analogue, GDC-0919 analogue) is a a potent IDO1 inhibitor with IC50 of 38 nM.
|
-
European Respiratory Journal, May 13, 2021, 2000443
-
Cell Death & Disease, July 19, 2019, 557
-
Acta Pharm Sin B, 2022, 12(6):2695-2709
|
|
| S7756 |
Indoximod
|
Indoximod, a methylated tryptophan, acts as an IDO (indoleamine-(2,3)-dioxygenase) pathway inhibitor, and reverses IDO-mediated immune suppression. Phase 2.This product has poor solubility, animal experiments are available, cell experiments please choose carefully!
|
-
eLife, October 5, 2020, e56749
-
European Respiratory Journal, May 13, 2021, 2000443
-
Front Immunol, 2024, 15:1331480
|
|
| S8957 |
Navoximod
|
Navoximod (GDC-0919, NLG-919) is a potent inhibitor of IDO (indoleamine-(2,3)-dioxygenase) pathway with Ki of 7 nM and EC50 of 75 nM.
|
-
Frontiers in Immunology, November 4, 2025, 16:1680896
-
ACS Nano, December 22, 2020, 17100-17113
-
J Colloid Interface Sci, 2025, 686:1019-1032
|
|
| S8657 |
PF-06840003
|
PF-06840003 (EOS200271) is a highly selective orally bioavailable IDO-1 inhibitor. Although this compound has moderate hIDO1 enzyme inhibition (IC50 0.41 μM), it is a highly efficient compound (LE 0.53, LipE 5.1), driven by its tight packing within the enzyme, as well as the high density of hydrogen bonds it forms with hIDO-1 despite its small size.
|
-
Cells, May 14, 2020, 1222
-
Frontiers in Immunology, 2023, 1100041
-
Front Immunol, 2023, 14:1100041
|
|
| S8629 |
Linrodostat (BMS-986205)
|
Linrodostat (BMS-986205, ONO-7701) is an irreversible inhibitor of IDO1 with an IC50 of 1.7 nM. It inhibits kynurenine production with IC50 values of 1.7, 1.1 and > 2000 in human HeLa, HEK293 expressing human IDO-1 and tryptophan-2, 3-dioxygenase cell-based assays.
|
-
Front Chem, 2022, 10:998013
-
Front Oncol, 2021, 11:679517
-
Eur Respir J, 2020, 2000443
|
|
| S8368 |
LM10
|
LM10 is a selective tryptophan 2,3-dioxygenase (TDO) inhibitor with IC50 values of 0.62 and 2 μM for human and mouse TDO, respectively.
|
-
Brain, Behavior, and Immunity, 2023, 173-186
-
Sci Adv, 2023, 9(5):eadd6995
-
Mol Med Rep, 2021, 23(6)445
|
|
| S8997 |
680C91
|
680C91 is a potent and selective inhibitor of TDO with Ki of 51 nM.
|
-
Cancer Research Communications, March 18, 2024, 822-833
-
Journal of Proteome Research, April 5, 2024, 1341-1350
-
Cancer Res Commun, 2024, 4(3):822-833
|
|
| S7587 |
Epacadostat (INCB024360) analogue
|
Epacadostat (INCB024360) analogue (INCB14943) is a potent, competitive IDO1 (indoleamine-(2,3)-dioxygenase) inhibitor with IC50 of 67 nM.
|
-
Biomed Pharmacother, 2024, 179:117412
-
Front Immunol, 2022, 13:966514
-
OncoImmunology, 2017, e1361594
|
|
| S8557 |
IDO inhibitor 1
|
IDO inhibitor 1 is a potent inhibitor of IDO (indoleamine-(2,3)-dioxygenase) with IC50 of 3 nM.
|
-
The Journal of Immunology, 2023 Jul 15, 261-273
-
The Journal of Immunology, 2023, 261-273
-
J Immunol, 2023, 211(2):261-273
|
|
| S9137 |
Erianin
|
Erianin, a natural product derived from Dendrobium chrysotoxum, has been used as an analgesic in traditional Chinese medicine and is a potential anti-tumor agent. This compound can inhibit IDO-induced tumor angiogenesis.
|
-
J Cancer, 2024, 15(8):2380-2390
|
|
| E0090 |
GNF-PF-3777
|
GNF-PF-3777 (8-Nitrotryptanthrin) is a potent human indoleamine 2, 3-dioxygenase 2 (hIDO2) inhibitor which significantly reduces IDO2 activity with Ki of 0.97 μM.
|
|
|
| S8919 |
LY-3381916
|
LY-3381916 (IDO1-IN-5) is a brain penetrated, potent and selective Indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor. This compound exhibits anti-tumor activity.
|
|
|
| S5249 |
Coptisine chloride
|
Coptisine (Q-100696, NSC-119754) is an isoquinoline alkaloid isolated from Coptidis Rhizoma with anti-diabetic, antimicrobial, antiviral, anti-hepatoma, and anti-leukemia effects. Coptisine chloride is an efficient uncompetitive IDO inhibitor with IC50 value of 6.3 μM and Ki value of 5.8 μM.
|
|
|
| S6728 |
IDO-IN-1
|
IDO-IN-1 is a potent indoleamine 2,3-dioxygenase (IDO) inhibitor with an IC50 of 59 nM.
|
|
|
| S8037 |
Necrostatin-1 (Nec-1)
|
Necrostatin-1 (Nec-1) is a specific RIP1 (RIPK1) inhibitor and inhibits TNF-α-induced necroptosis with EC50 of 490 nM in 293T cells. Necrostatin-1 also blocks IDO and suppresses autophagy and apoptosis.
|
-
Cell Res, 2025, 10.1038/s41422-025-01167-8
-
Signal Transduct Target Ther, 2025, 10(1):341
-
Cancer Discov, 2025, 10.1158/2159-8290.CD-24-1317
|
|